Imura et al., 2019 - Google Patents
Differential expression of a stress‐regulated gene Nr4a2 characterizes early‐and late‐born hippocampal granule cellsImura et al., 2019
View PDF- Document ID
- 6520444415606178906
- Author
- Imura T
- Kobayashi Y
- Suzutani K
- Ichikawa‐Tomikawa N
- Chiba H
- Publication year
- Publication venue
- Hippocampus
External Links
Snippet
Neural progenitors acquire GFAP expression during the perinatal period and continue to generate granule cells (GCs) in the hippocampal dentate gyrus throughout adulthood. Cellular characteristics of GFAP+ progenitor‐derived late‐born GCs in comparison with …
- 101710004289 RRM1 0 title abstract description 99
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shi et al. | Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons | |
Wang et al. | A pivotal role of FOS-mediated BECN1/Beclin 1 upregulation in dopamine D2 and D3 receptor agonist-induced autophagy activation | |
Panja et al. | Two-stage translational control of dentate gyrus LTP consolidation is mediated by sustained BDNF-TrkB signaling to MNK | |
Kim et al. | The apical complex couples cell fate and cell survival to cerebral cortical development | |
Miyata et al. | Disturbance of oligodendrocyte function plays a key role in the pathogenesis of schizophrenia and major depressive disorder | |
Tezuka et al. | Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis | |
Francelle et al. | Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease | |
Deng et al. | miR-214-3p targets β-catenin to regulate depressive-like behaviors induced by chronic social defeat stress in mice | |
Mifsud et al. | Distinct regulation of hippocampal neuroplasticity and ciliary genes by corticosteroid receptors | |
Sawano et al. | Thyroid hormone-dependent development of the GABAergic pre-and post-synaptic components in the rat hippocampus | |
Wang et al. | Developmental cytoplasmic-to-nuclear translocation of RNA-binding protein HuR is required for adult neurogenesis | |
Mo et al. | Early growth response 1 (Egr‐1) directly regulates GABAA receptor α2, α4, and θ subunits in the hippocampus | |
Kara et al. | The miR-216a-Dot1l regulatory axis is necessary and sufficient for Müller glia reprogramming during retina regeneration | |
Ren et al. | Downregulated nuclear factor E2-related factor 2 (Nrf2) aggravates cognitive impairments via neuroinflammation and synaptic plasticity in the senescence-accelerated mouse prone 8 (SAMP8) mouse: a model of accelerated senescence | |
Kiryk et al. | Impaired rRNA synthesis triggers homeostatic responses in hippocampal neurons | |
Lui et al. | Lhx1/5 control dendritogenesis and spine morphogenesis of Purkinje cells via regulation of Espin | |
Hornsby et al. | Unacylated-ghrelin impairs hippocampal neurogenesis and memory in mice and is altered in Parkinson’s dementia in humans | |
Bird et al. | Identification of glucocorticoid‐regulated genes that control cell proliferation during murine respiratory development | |
Imura et al. | Differential expression of a stress‐regulated gene Nr4a2 characterizes early‐and late‐born hippocampal granule cells | |
Ishida et al. | Dorsal telencephalon-specific Nprl2-and Nprl3-knockout mice: novel mouse models for GATORopathy | |
Cao et al. | NMDA receptor hypofunction underlies deficits in parvalbumin interneurons and social behavior in neuroligin 3 R451C knockin mice | |
Treccani et al. | Early life adversity targets the transcriptional signature of hippocampal NG2+ glia and affects voltage gated sodium (Nav) channels properties | |
Silberman et al. | Ethanol produces corticotropin‐releasing factor receptor‐dependent enhancement of spontaneous glutamatergic transmission in the mouse central amygdala | |
Han et al. | Isoproterenol-induced hypertrophy of neonatal cardiac myocytes and H9c2 cell is dependent on TRPC3-regulated CaV1. 2 expression | |
Kikuchi et al. | Involvement of SRF coactivator MKL 2 in BDNF‐mediated activation of the synaptic activity‐responsive element in the Arc gene |